Copyright 2001 eMediaMillWorks, Inc.
(f/k/a Federal
Document Clearing House, Inc.)
Federal Document Clearing House
Congressional Testimony
March 28, 2001, Wednesday
SECTION: CAPITOL HILL HEARING TESTIMONY
LENGTH: 854 words
COMMITTEE:
HOUSE ENERGY AND COMMERCE
HEADLINE:
TESTIMONY OVERSIGNT OF
HUMAN CLONING RESEARCH
TESTIMONY-BY: BOBBY L. RUSH , REPRESENTATIVE
BODY: March 28, 2001 Opening Statement of U.S. Rep.
Bobby L. Rush Hearing on Issues Raised b
Human Cloning Research
I want to thank you for holding this hearing on such a contentious and emotional
issue. With Scottish scientist Ian Wilmut's cloning of an adult sheep, Dolly, in
February of 1997, we all knew that it was only a matter of time before attempts
would be made to clone a human. Based on my own personal, moral and religious
views, I believe that
human cloning raises ethical, religious
and moral concerns. However, as co-chair of the House Biotech Caucus I am well
aware of the amazing advances science and technology have made in both the
medical and agricultural fields to prolong and improve the quality of human
life. As an African American, I believe we must look at the ethics of how we
intend to act. The expansion of science is not an end unto itself. The expansion
of science must be viewed in light of the agenda of those who espouse it and the
impact it has on the public. Efficacy is also a major concern. Even if we simply
viewed cloning from a purely scientific perspective, devoid of moral
considerations, there are major problems. Many prominent scientist have reported
that cloning has resulted in developmental delays, heart defects, lung problems
and malfunctioning immune systems in mammals. Also, the errors created by
cloning are random and may not surface until later life. Thus, until long-term
research is done on cloning, we will not know the impact cloning has as cloned
species age. The FDA would not release a drug for human consumption which caused
major birth defects in lab animals and could therefore harm humans. Based on
this same logic, cloning should not be considered for humans until these
efficacy issues are addressed. The danger of cloning as a public health concern
reaches beyond the cloned infant. The physical and genetic abnormalities of a
cloned infant may pose a significant threat to the life and health of the
surrogate mother. While it is clear that there are serious problems with
human cloning due to moral and public health concerns, I do
think that prudence is warranted. As noted, science and the biotech field have
brought us many great successes. We must not take action which would impede the
legitimate and safe use of biotechnology. Many argue Congress is slow to react
to changes in science and technology. I would argue that we must act with
caution to ensure the future scientific successes which will make this world
healthier and more productive while tightly regulating those practices which
pose a clear threat to the health and safety of our citizens.
LOAD-DATE: March 30, 2001, Friday